REMS testing for osteoporosis diagnosis and fracture risk in adults compared with DXA
Official title: Estimation of the Effectiveness of Radiofrequency Echographic Multi Spectrometry (REMS) for the Diagnosis of Osteoporosis and Fracture Risk Prediction in the United States in Comparison With Dual-Energy X-Ray Absorptiometry (DXA)
Run by BoneVue Diagnostics · NCT07876882 · Data updated 2026-11-12
This study tests whether REMS can diagnose osteoporosis and predict fracture risk in adults who are being evaluated for bone health, using DXA as the standard reference.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 30 Years to 90 Years |
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | BoneVue Diagnostics Academic / other |
| Locations | 2 sites (Easton, Maryland and 1 other locations) |
| Status | Recruiting |
| Started | June 24, 2026 |
| Main results expected | December 24, 2027 |
| Study ends | December 24, 2027 |
| Registry record updated | October 15, 2026 |
| Trial ID | NCT07876882 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults ages 30–90 undergoing bone-health evaluation who have had a clinically ordered DXA within the prior seven days and can complete follow-up calls.
✕Probably not a fit
Individuals not expected to benefit include those with conditions or factors that preclude reliable REMS examination or study follow-up, or those who have not had a recent DXA.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective observational study compares Radiofrequency Echographic Multi Spectrometry (REMS) to dual-energy X-ray absorptiometry (DXA) for diagnosing osteoporosis and predicting fragility fractures. Enrolling about 250 men and women aged 30–90 undergoing bone-health evaluation, all participants will have a prior DXA and will receive a REMS assessment of the lumbar spine and proximal femur. Diagnostic performance will be analyzed in terms of sensitivity, specificity, predictive values, and concordance with DXA. Participants will be followed by telephone at 6 and 12 months to identify incident non-traumatic fragility fractures and to assess how well REMS and DXA predict fracture risk.
Why it matters
Potential benefit: If successful, REMS could provide an alternative or complementary method for osteoporosis diagnosis and fracture risk prediction alongside DXA.
How similar studies have gone: Prior studies have explored REMS in bone health with promising diagnostic concordance to DXA, but broader validation remains ongoing.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 30-90 years at time of enrollment * Presenting for evaluation of bone health or osteoporosis risk assessment * Has undergone a clinically ordered DXA scan (lumbar spine, proximal femur) as part of routine medical care through the subject's healthcare provider within the seven days immediately preceding the REMS examination * Willing and able to provide written informed consent * Able to comply with study procedures, including telephone follow-up interviews at 6- and 12-months post-enrollment Exclusion Criteria: * Inability to provide written informed consent * Inability to complete an adequate REMS examination * Declared pregnancy as collected per standard of care prior to DXA
Where it's running
-
Rheumatology Associates of Delmarva
Easton, Maryland, United States Recruiting -
Rheumatology Associates of Delmarva
Salisbury, Maryland, United States Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if a new tomosynthesis imaging tool helps diagnose MSK issues in ED and clinic
This study tests whether the Nanox.ARC Digital Tomosynthesis system can add diagnostic value for adults with suspected MSK problems and potentially reduce the need for CT or MRI.
-
Bone health and vitamin D for pregnant women with epilepsy
We’re testing whether giving calcium and vitamin D to women with epilepsy who are trying to become or are early in pregnancy helps pregnancy outcomes and bone health.
-
Fermented foods and bone health in vegan women
This study tests whether daily fermented plant-based foods can improve bone health in premenopausal vegan women by potentially enhancing mineral absorption through the gut.
-
Dairy versus plant-based yogurt effects on weight, muscle, bones, and gut bacteria
This study will test whether eating dairy yogurt instead of a plant-based yogurt (or no yogurt) helps postmenopausal women with overweight or obesity maintain muscle and bone health, control weight, and change gut bacteria.
-
See how well iFuse TORQ TNT works for pelvic fragility fractures
This study tests the iFuse TORQ TNT implant in older adults with pelvic fragility fractures to see if real-world use leads to better outcomes.
-
Buprenorphine for pain relief in older adults with broken bones in the ED
This study tests whether buprenorphine can safely and effectively relieve pain in older adults with acute fractures, compared with hydromorphone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.